Dr. Lavinia Alberi, Ph.D., PD, MBA
Dr. Alberi is managing director of the Swiss Integrative Center for Human Health (SICHH) in Fribourg Switzerland and is Assistant Professor at the University of Fribourg.
She is founding member of the advocacy campaign BrainFit4Life and senior editor of Frontiers Neuroscience since 2010. Her work spans diagnostic and therapeutic models in AD and she is an expertise in olfaction and microbial diagnostics for early dementia detection. From 2020, her team helped in the COVID pandemic surveillance by developing and patenting a salivary COVID test and is now developing other salivary diagnostic applications in preventive medicine.
She holds a Ph.D. in Neuroscience from the University of Heidelberg, Germany and was a Postdoctoral Fellow in the Neurology Department at Johns Hopkins School of Medicine, Baltimore, where she worked on the role of Notch signaling in memory and stroke. From 2012, she has been an independent PI at the University of Fribourg, Switzerland and subsequently Lead in Neurology at SICHH.
Her work on the molecular mechanisms of AD coupled with her research on olfaction and the infectious hypothesis of neurodegenerative dementia have been featured on Alzforum and nationalpress.